Jefferies Group’s ICU Medical ICUI Stock Holding History

Jefferies Group’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-15,000	Closed	-$3.5M	–	1802
2021 Q3	$3.5M	Buy	+15,000	New	+$3.15M	0.03%	545

Other funds holding ICUI

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Jefferies Group's ICUI Position: Q3 2022 in Review

Jefferies Group sold out of ICU Medical (ICUI) in Q3 2022, closing a stake of 2,900 shares — an estimated $477K sold.

Jefferies Group first reported a position in ICUI in Q3 2014 and held it in 9 quarters. The position peaked at $806K in Q3 2017. 243 funds tracked by Wall St. Rank hold ICUI as of Q3 2022.

Jefferies Group reported no remaining ICU Medical position as of Q3 2022 after selling out during the quarter.
Jefferies Group sold 2,900 ICU Medical shares in Q3 2022, an estimated $477K.
Jefferies Group first reported a position in ICU Medical in Q3 2014 and held it in 9 quarters.
Jefferies Group's ICU Medical position peaked at $806K in Q3 2017.
243 funds tracked by Wall St. Rank held ICU Medical as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.